Acute and Long-Term Effects of Prostaglandin E <sub>1</sub> Assessed by Clinical and Microcirculatory Parameters in Critical Limb Ischemia: A Pilot Study

Hans Stricker(University Hospital of Bern), F Mahler(University Hospital of Bern), J Frei(University Hospital of Bern), Ulrich Kaiser(University of Applied Sciences Landshut)
International Journal of Microcirculation
November 25, 2008
10.1159/000179151
Cited by 10

Related Papers

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
|The Lancet|2013|1.5k
Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length
|Circulation|2007|515
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
|The Lancet Oncology|2015|402
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
|Annals of Oncology|2006|280
<i>CEBPA</i> mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome
|Blood|2021|170